Search
Portfolio
SGX
Google
Yahoo
TradingView
IX BIOPHARMA LTD. (42C)
SGD 0.375
-1.33% -0.01
Portfolio
Watchlist
Div
Anns
News
Info
Trans
Note
Yahoo Finance Singapore
5 days ago
iX Biopharma allots close to 2.92 mil new shares following warrant exercise
TradingView
22 days ago
iX Biopharma Ltd. Actuals & Estimates (SGX:42C)
TradingView
a month ago
Number of shareholders of iX Biopharma Ltd. – SGX:42C
The Edge Singapore
a month ago
Pain relief for GI Joes, giant leap for iX Biopharma
Moomoo
a month ago
IX Biopharma Allots, Issues New Shares
Moomoo
2 months ago
IX Biopharma Allots, Issues More Shares
Moomoo
2 months ago
IX Biopharma Narrows Loss in Fiscal Q3
TipRanks
2 months ago
iX Biopharma Wins Conditional SGX Nod for New Share Placement
world.infonasional.com
3 months ago
IX Biopharma Aims to Lead Non-Opioid Pain Relief with Wafermine
The Business Times
3 months ago
Singapore-listed IX Biopharma bets big on non-opioid pain relief
The Edge Singapore
3 months ago
PhillipCapital re-initiates coverage on iX Biopharma with target price of $1
Yahoo Finance Singapore
3 months ago
iX Biopharma issues 10 mil new ordinary shares at exercise price of six cents each
Yahoo Finance Singapore
3 months ago
iX Biopharma's executive chairman injects $600,000 into company via exercise of warrants
Yahoo Finance Singapore
4 months ago
Forget 2.5%: These 5 SGX Stocks Pay Double Your CPF OA
Singapore Business Review
4 months ago
iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement
Yahoo Finance Singapore
5 months ago
Budget 2026 Injects Another S$1.5 Billion Into SGX. Are Singapore Mid-Cap Stocks About to Surge?
Singapore Business Review
5 months ago
iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue
The Edge Singapore
5 months ago
iX Biopharma reports lower net loss for 1HFY2026
Yahoo Finance Singapore
5 months ago
3 Singapore Stocks to Watch in the Week of 9 February 2026
Yahoo Finance Singapore
5 months ago
3 Blue Chip Stocks That Could Benefit if SGX Reduces Board Lot Size
«
Previous
1
2
3
»
Next
© 2026 Dividends.sg